Security key
N44821101
InflaRx N.V. - Ordinary Shares, nominal value 0.12 EUR per share (the "Shares") (IFRX)
CUSIP: N44821101
Q2 2020 13F Holders as of 30 Jun 2020
- Security type / class
- Equity / Ordinary Shares, nominal value 0.12 EUR per share (the "Shares")
- Total 13F shares
- 3,501,150
- Total 13F value
- $16,070,000
- Share change
- -1,516,605
- Put/Call ratio
- 694%
- SEC-reported price per share
- $4.59
- Number of holders
- 34
- Value change
- -$6,253,771
- Number of buys
- 22
- Number of sells
- 17
- Shares outstanding
- 147,058,824
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
34
Top holders
10
IFRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2020
Previous quarter: Q1 2020
InflaRx N.V. SEC filings
InflaRx N.V. company facts
Broader feeds
Reporting periods
Holder history for CUSIP N44821101
Recent filing periods:
Ownership snapshot
Top reported holders of IFRX - InflaRx N.V. - Ordinary Shares, nominal value 0.12 EUR per share (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F
Lead comparable stake: 1.2%
Showing 1-6 of 15 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 1.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
1.2%
ORBIMED ADVISORS LLC
0.73%
CITADEL ADVISORS LLC
0.37%
FNY Investment Advisers, LLC
0.25%
Ikarian Capital, LLC
0.18%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
Company
|
1.2%
|
$6,794,000
1,778,415 shares
|
— | 31 Mar 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.73%
|
$4,078,000
1,067,600 shares
|
— | 31 Mar 2020 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.37%
|
$2,106,000
551,274 shares
|
— | 31 Mar 2020 |
| FNY Investment Advisers, LLC |
13F
Company
|
0.25%
|
$1,413,000
370,000 shares
|
— | 31 Mar 2020 |
| Ikarian Capital, LLC |
13F
Company
|
0.18%
|
$1,003,000
262,600 shares
|
— | 31 Mar 2020 |
| Eversept Partners, LP |
13F
Company
|
0.13%
|
$746,764
195,488 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
34
Shares
3,501,150
Rows available
34
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
22
Q2 2020 holders
34
Holder diff
12
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend